OncRef

Clinical Trial: NCT05401643

Evaluation of the Impact of a Multidimensional ICT Intervention on the Quality of Life of Breast Cancer Survivors

Status:

COMPLETED

Phase:

Not Applicable

Lead Sponsor:Fundacion Clinic per a la Recerca Biomédica
Information Provided By:Fundacion Clinic per a la Recerca Biomédica
Last Update Posted:2024-02-28

Study Overview

Brief Summary

mACMA is a pilot study that is developed for breast cancer survivors of the Hospital Clinic of Barcelona. The objective of this study is to evaluate the progress in quality of life through the introduction of a mobile phone App that allows for symptom tracking, physical activity tracking and a calendar of patient-oriented events organized by patient organizations. This study is a two-arm randomized clinical trial.

This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 875351.

Official Title

Evaluación Del Impacto de Una intervención Multidimensional, Con Herramientas TIC, en la Calidad de Vida de Las Pacientes Supervivientes al cáncer de Mama

Conditions

Breast Cancer, Breast Neoplasms, Quality of Life, Survivorship

Intervention / Treatment

  • Other: Xemio mobile application

Other Study ID Numbers

  • HCB/2020/0971

Start Date (Actual)

2020-11-01

Primary Completion Date (Actual)

2022-11-30

Study Completion Date (Actual)

2023-06-30

Enrollment (Actual)

110

Study Type

Interventional

Phase

Not Applicable